To study the effect of injection magnesium sulphate on responses to heart rate and blood pressure during intubation in surgeries of ear, nose and throat
Phase 2
- Conditions
- Health Condition 1: H758- Other specified disorders of middle ear and mastoid in diseases classified elsewhere
- Registration Number
- CTRI/2023/08/055967
- Lead Sponsor
- Jawaharlal Nehru Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Weight between 40-65 kg, either gender , ASA physical status I and II, patients undergoing elective ENT surgery.
Exclusion Criteria
Patient refusal , emergency surgery. History of cardiovascular , pulmonary, renal , hepatic , endocrinal or neurological disease. Preoperative hypotension , patients on antipsychotics. Patient on digitalis , calcium channel blockers and alpha & beta agonist or antagonist . Sinus bradycardia, heart blocks, conduction defects. Obesity, pregnancy , lactation, anticipated difficult airway, allergy to study drugs. Any change needed in the technique of anesthesia or duration of laryngoscopy for >30 seconds.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Magnesium sulphate is effective in suppressing the haemodynamic responses to laryngoscopy & tracheal intubation in surgeries of ear, nose & throat.Timepoint: Until 5 minutes after laryngoscopy
- Secondary Outcome Measures
Name Time Method To observe the incidence & severity of adverse effects of intravenous magnesium sulphate, if any.Timepoint: Until 5 minutes after laryngoscopy